135 related articles for article (PubMed ID: 16682196)
1. Cyclobutane derivatives as potent NK1 selective antagonists.
Wrobleski ML; Reichard GA; Paliwal S; Shah S; Tsui HC; Duffy RA; Lachowicz JE; Morgan CA; Varty GB; Shih NY
Bioorg Med Chem Lett; 2006 Jul; 16(14):3859-63. PubMed ID: 16682196
[TBL] [Abstract][Full Text] [Related]
2. Cyclic urea derivatives as potent NK1 selective antagonists.
Shue HJ; Chen X; Shih NY; Blythin DJ; Paliwal S; Lin L; Gu D; Schwerdt JH; Shah S; Reichard GA; Piwinski JJ; Duffy RA; Lachowicz JE; Coffin VL; Liu F; Nomeir AA; Morgan CA; Varty GB
Bioorg Med Chem Lett; 2005 Sep; 15(17):3896-9. PubMed ID: 16019209
[TBL] [Abstract][Full Text] [Related]
3. Cyclic urea derivatives as potent NK1 selective antagonists. Part II: Effects of fluoro and benzylic methyl substitutions.
Shue HJ; Chen X; Schwerdt JH; Paliwal S; Blythin DJ; Lin L; Gu D; Wang C; Reichard GA; Wang H; Piwinski JJ; Duffy RA; Lachowicz JE; Coffin VL; Nomeir AA; Morgan CA; Varty GB; Shih NY
Bioorg Med Chem Lett; 2006 Feb; 16(4):1065-9. PubMed ID: 16290143
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of novel, highly potent, selective, and orally active CCR1 antagonists.
Xie YF; Lake K; Ligsay K; Komandla M; Sircar I; Nagarajan G; Li J; Xu K; Parise J; Schneider L; Huang D; Liu J; Dines K; Sakurai N; Barbosa M; Jack R
Bioorg Med Chem Lett; 2007 Jun; 17(12):3367-72. PubMed ID: 17446072
[TBL] [Abstract][Full Text] [Related]
5. 2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain models.
Walpole C; Ko SY; Brown M; Beattie D; Campbell E; Dickenson F; Ewan S; Hughes GA; Lemaire M; Lerpiniere J; Patel S; Urban L
J Med Chem; 1998 Aug; 41(17):3159-73. PubMed ID: 9703462
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel, potent and orally active series of gamma-lactams as selective NK1 antagonists.
Paliwal S; Reichard GA; Shah S; Wrobleski ML; Wang C; Stengone C; Tsui HC; Xiao D; Duffy RA; Lachowicz JE; Nomeir AA; Varty GB; Shih NY
Bioorg Med Chem Lett; 2008 Jul; 18(14):4168-71. PubMed ID: 18547807
[TBL] [Abstract][Full Text] [Related]
7. Novel 2-aminotetralin and 3-aminochroman derivatives as selective serotonin 5-HT7 receptor agonists and antagonists.
Holmberg P; Sohn D; Leideborg R; Caldirola P; Zlatoidsky P; Hanson S; Mohell N; Rosqvist S; Nordvall G; Johansson AM; Johansson R
J Med Chem; 2004 Jul; 47(16):3927-30. PubMed ID: 15267230
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonists.
Lai G; Merritt JR; He Z; Feng D; Chao J; Czarniecki MF; Rokosz LL; Stauffer TM; Rindgen D; Taveras AG
Bioorg Med Chem Lett; 2008 Mar; 18(6):1864-8. PubMed ID: 18304809
[TBL] [Abstract][Full Text] [Related]
9. 4,4-Disubstituted piperidine high-affinity NK1 antagonists: structure-activity relationships and in vivo activity.
Stevenson GI; Huscroft I; MacLeod AM; Swain CJ; Cascieri MA; Chicchi GG; Graham MI; Harrison T; Kelleher FJ; Kurtz M; Ladduwahetty T; Merchant KJ; Metzger JM; MacIntyre DE; Sadowski S; Sohal B; Owens AP
J Med Chem; 1998 Nov; 41(23):4623-35. PubMed ID: 9804702
[TBL] [Abstract][Full Text] [Related]
10. Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist.
Di Fabio R; Griffante C; Alvaro G; Pentassuglia G; Pizzi DA; Donati D; Rossi T; Guercio G; Mattioli M; Cimarosti Z; Marchioro C; Provera S; Zonzini L; Montanari D; Melotto S; Gerrard PA; Trist DG; Ratti E; Corsi M
J Med Chem; 2009 May; 52(10):3238-47. PubMed ID: 19388677
[TBL] [Abstract][Full Text] [Related]
11. Axially chiral N-benzyl-N,7-dimethyl-5-phenyl-1, 7-naphthyridine-6-carboxamide derivatives as tachykinin NK1 receptor antagonists: determination of the absolute stereochemical requirements.
Ikeura Y; Ishichi Y; Tanaka T; Fujishima A; Murabayashi M; Kawada M; Ishimaru T; Kamo I; Doi T; Natsugari H
J Med Chem; 1998 Oct; 41(22):4232-9. PubMed ID: 9784098
[TBL] [Abstract][Full Text] [Related]
12. Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonists.
Liu KG; Robichaud AJ; Greenfield AA; Lo JR; Grosanu C; Mattes JF; Cai Y; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Comery TA
Bioorg Med Chem; 2011 Jan; 19(1):650-62. PubMed ID: 21093272
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potent, balanced and orally active dual NK1/NK3 receptor ligands.
Peters JU; Hoffmann T; Schnider P; Stadler H; Koblet A; Alker A; Poli SM; Ballard TM; Spooren W; Steward L; Sleight AJ
Bioorg Med Chem Lett; 2010 Jun; 20(11):3405-8. PubMed ID: 20430616
[TBL] [Abstract][Full Text] [Related]
14. Tetrahydroindolizinone NK1 antagonists.
Bao J; Lu H; Morriello GJ; Carlson EJ; Wheeldon A; Chicchi GG; Kurtz MM; Tsao KL; Zheng S; Tong X; Mills SG; DeVita RJ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2354-8. PubMed ID: 20188553
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry.
Corbett DF; Heightman TD; Moss SF; Bromidge SM; Coggon SA; Longley MJ; Roa AM; Williams JA; Thomas DR
Bioorg Med Chem Lett; 2005 Sep; 15(18):4014-8. PubMed ID: 16002289
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.
Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F
J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869
[TBL] [Abstract][Full Text] [Related]
17. 1-(1-phenethylpiperidin-4-yl)-1-phenylethanols as potent and highly selective 5-HT2A antagonists.
Heinrich T; Böttcher H; Prücher H; Gottschlich R; Ackermann KA; van Amsterdam C
ChemMedChem; 2006 Feb; 1(2):245-55. PubMed ID: 16892357
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists.
Hoffmann T; Bös M; Stadler H; Schnider P; Hunkeler W; Godel T; Galley G; Ballard TM; Higgins GA; Poli SM; Sleight AJ
Bioorg Med Chem Lett; 2006 Mar; 16(5):1362-5. PubMed ID: 16332435
[TBL] [Abstract][Full Text] [Related]
19. Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amides.
Urbahns K; Härter M; Albers M; Schmidt D; Stelte-Ludwig B; Brüggemeier U; Vaupel A; Keldenich J; Lustig K; Tsujishita H; Gerdes C
Bioorg Med Chem Lett; 2007 Nov; 17(22):6151-4. PubMed ID: 17910915
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists.
Yu Y; Dwyer MP; Chao J; Aki C; Chao J; Purakkattle B; Rindgen D; Bond R; Mayer-Ezel R; Jakway J; Qiu H; Hipkin RW; Fossetta J; Gonsiorek W; Bian H; Fan X; Terminelli C; Fine J; Lundell D; Merritt JR; He Z; Lai G; Wu M; Taveras A
Bioorg Med Chem Lett; 2008 Feb; 18(4):1318-22. PubMed ID: 18242983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
